The National Intellectual Property Administration's Patent Office conducted an in-depth research at Chuangyuan Biotechnology to help accelerate the company's intellectual property layout.

On September 5, a delegation led by Deputy Director Jiang Hui of the Pharmaceutical and Biological Invention Examination Department of the National Intellectual Property Administration's Patent Office (hereinafter referred to as the "Pharmaceutical and Biological Department") conducted an in-depth investigation at Tianjin Chuangyuan Biotechnology Co., Ltd. to assess the company's intellectual property development and held a special discussion on related patent issues in the field of biomedicine. Relevant personnel from the Patent Examination Cooperation Tianjin Center's Pharmaceutical Chemistry Invention Examination Department attended the event. Chuangyuan Biotechnology's Executive Vice President Shi Yali, Vice President, Chief Engineer, and Chief Scientist Dr. Wang Haikuan, along with heads of relevant departments, accompanied the visit.

The investigation team comprehensively understood the company's situation regarding intellectual property, independent research and development capabilities, patent applications for technological achievements, and difficulties in patent applications through on-site visits, listening to reports, and engaging in discussions. They also conducted in-depth discussions on the innovation of invention patents and the issues encountered in the transformation and application of intellectual property.

This research exchange has brought new ideas for the management and application of intellectual property in enterprises. In the future, Chuangyuan Biotechnology will continue to promote the development of intellectual property work with the help of the National Intellectual Property Administration's Patent Office, enhance its professional capabilities, fulfill corporate social responsibilities, and support continuous innovation in technology in the micro-ecology field, output intellectual property patents, and provide solid support for high-level technological innovation.

Full of affection during the Mid-Autumn Festival, Chuangyuan Biotech provides benefits to all employees.

The first 'Labor Skills Competition' of Chuangyuan Biotechnology has successfully concluded.

Full of affection during the Mid-Autumn Festival, Chuangyuan Biotech provides benefits to all employees.

The first 'Labor Skills Competition' of Chuangyuan Biotechnology has successfully concluded.

2024-12-23

In December 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. and Haihe Dairy jointly held a series of themed activities titled "Party Building Mutual Visits and Learning" to further promote the deep integration of both parties' party building work and business development. During the event, both sides will conduct company visits and on-site discussions. Recently, Haihe Dairy made an initial visit and, after gaining a deep understanding of Chuangyuan Biotech's products, expressed high recognition and close attention, laying a solid foundation for future cooperation. Subsequently, both parties engaged in detailed communication on the core topics of "exchange of party building experiences and sharing of business resources," discussing standardized construction of party branches, distinctive party building measures, and the promotion of party-business integration. They also conducted in-depth exchanges on aspects such as corporate cooperation, product intercommunication, and information sharing, jointly exploring new paths for the development of the health industry under the guidance of party building, providing more possibilities for further establishing a "symbiotic, mutually promoting, and win-win" cooperative relationship. Both parties hope to achieve industrial resonance through party building leadership and contribute to the development of the health industry in the Binhai New Area.

Strength crowned, Chuangyuan Biotechnology won two Science and Technology Awards from the China Food Industry Association.

2024-12-17

On December 16, 2024, the 22nd China Food Safety Conference and the 2024 National Food Industry Science and Technology Progress Conference, themed "Implementing Food Safety Strategy to Support the Construction of a Healthy China," was grandly held in Beijing. During the conference, the award ceremony for the 2024 National Food Industry Science and Technology Progress Conference was also held. Tianjin Chuangyuan Biotechnology Co., Ltd. won the second prize for scientific and technological progress in the "2023 China Food Industry Association Science and Technology Award" for two projects: "Key Technology Breakthrough and Industrial Application of New Postbiotics Segmented Solid-State Fermentation" and "Development and Application of Key Technologies and Equipment for Plant Polysaccharide Efficacy Verification and Extraction."

Chuangyuan Biotech's lactic acid bacteria IOB701 post-fermentation probiotic powder has been granted a national invention patent.

2024-12-13

On December 13, 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. received an invention patent certificate from the National Intellectual Property Administration for its independently developed and filed method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder (Patent No.: ZL 202411354886.X). This invention provides a method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder, which relates to the field of microbiology. The Lactobacillus plantarum IOB701 was preserved on July 10, 2018, at the General Microbial Culture Collection Center of the China Microbial Strain Preservation Management Committee, abbreviated as CGMCC, with the preservation address at No. 3, Courtyard 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number CGMCC No. 16077. Using grains or legumes treated with low oxygen stress as the fermentation substrate, the Lactobacillus plantarum IOB701 fermentation resulted in postbiotics powder, which, according to animal experiments, has been shown to improve chronic unpredictable mild stress-induced depressive-like behavior in mice.

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Jin Gong Wang An Bei No. 12019202000539

Business License